title: [Pharmacological, pharmacokinetic, and clinical profile of itraconazole oral solution (ITRIZOLE Oral Solution 1%)].
authors.affiliation: HOTANI@JANJP.JNJ.com
authors.forename: Hisaya
authors.initials: H
authors.lastname: Otani
authors.forename: Kouichi
authors.initials: K
authors.lastname: Inoue
authors.forename: Tetsuhiro
authors.initials: T
authors.lastname: Shiota
authors.forename: Yasumasa
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Shunji
authors.initials: S
authors.lastname: Nomura
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Harada
authors.forename: Hiroko
authors.initials: H
authors.lastname: Ishibashi
authors.forename: Shigeru
authors.initials: S
authors.lastname: Abe
authors.forename: Katsuhisa
authors.initials: K
authors.lastname: Uchida
authors.forename: Hideyo
authors.initials: H
authors.lastname: Yamaguchi
authors.forename: Shinichi
authors.initials: S
authors.lastname: Torii
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D002180:Candidiasis, Oral / Q000188:drug therapy* / Q000382:microbiology; D004195:Disease Models, Animal; D025141:Drug Resistance, Fungal; D005658:Fungi / Q000187:drug effects; D006801:Humans; D007408:Intestinal Absorption; D017964:Itraconazole / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D016032:Randomized Controlled Trials as Topic; D012996:Solutions
chemical_list: D000935:Antifungal Agents; D012996:Solutions; D017964:Itraconazole